{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T11:15:24Z","timestamp":1793445324682,"version":"4.5.0"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"28","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1097\/md.0000000000004267","type":"journal-article","created":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T14:54:44Z","timestamp":1468508084000},"page":"e4267","source":"Crossref","is-referenced-by-count":13,"title":["Clinical features of Crohn disease concomitant with ankylosing spondylitis"],"prefix":"10.1097","volume":"95","author":[{"given":"Song","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanqing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxian","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-62-20210226","doi-asserted-by":"crossref","first-page":"590467","DOI":"10.1155\/2014\/590467","article-title":"Geographic mapping of Crohn's disease and its relation to affluence in jiangsu province, an eastern coastal province of china","volume":"2014","author":"Hu","year":"2014","journal-title":"Gastroenterol Res Pract"},{"key":"R2-62-20210226","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3109\/00365521.2014.991752","article-title":"Extraintestinal manifestations in Crohn's disease and ulcerative colitis: results from a prospective, population-based European inception cohort","volume":"50","author":"Isene","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"R3-62-20210226","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/ibd.21417","article-title":"Long-term complications, extraintestinal manifestations, and mortality in adult Crohn's disease in population-based cohorts","volume":"17","author":"Peyrin-Biroulet","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"R4-62-20210226","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1097\/MIB.0000000000000392","article-title":"Extraintestinal manifestations of inflammatory bowel disease","volume":"21","author":"Vavricka","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"R5-62-20210226","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.3899\/jrheum.120321","article-title":"Incidence of spondyloarthropathy in patients with Crohn's disease: a population-based study","volume":"39","author":"Shivashankar","year":"2012","journal-title":"J Rheumatol"},{"key":"R6-62-20210226","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1007\/s10620-014-3160-0","article-title":"Clinical presentation and disease course of inflammatory bowel disease differs by race in a large tertiary care hospital","volume":"59","author":"Sofia","year":"2014","journal-title":"Dig Dis Sci"},{"key":"R7-62-20210226","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","article-title":"The central role of the propensity score in observational studies for causal effects","volume":"70","author":"Rosenbaum","year":"1983","journal-title":"Biometrika"},{"key":"R8-62-20210226","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/ibd.21048","article-title":"World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010","volume":"16","author":"Bernstein","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"R9-62-20210226","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","article-title":"Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria","volume":"27","author":"van der Linden","year":"1984","journal-title":"Arthritis Rheum"},{"key":"R10-62-20210226","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.2005.082909","article-title":"The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications","volume":"55","author":"Satsangi","year":"2006","journal-title":"Gut"},{"key":"R11-62-20210226","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0016-5085(76)80163-1","article-title":"Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study","volume":"70","author":"Best","year":"1976","journal-title":"Gastroenterology"},{"key":"R12-62-20210226","first-page":"2281","article-title":"A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index","volume":"21","author":"Calin","year":"1994","journal-title":"J Rheumatol"},{"key":"R13-62-20210226","first-page":"2286","article-title":"A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index","volume":"21","author":"Garrett","year":"1994","journal-title":"J Rheumatol"},{"key":"R14-62-20210226","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1097\/00054725-200409000-00022","article-title":"The epidemiology and phenotype of Crohn's disease in the Chinese population","volume":"10","author":"Leong","year":"2004","journal-title":"Inflamm Bowel Dis"},{"key":"R15-62-20210226","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s00296-008-0811-5","article-title":"Prevalence of spondyloarthritis in Turkish patients with inflammatory bowel disease","volume":"29","author":"Beslek","year":"2009","journal-title":"RheumatolInt"},{"key":"R16-62-20210226","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/ajg.2010.343","article-title":"Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort","volume":"106","author":"Vavricka","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"R17-62-20210226","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1572-0241.2001.03756.x","article-title":"The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study","volume":"96","author":"Bernstein","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R18-62-20210226","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/ibd.20406","article-title":"Autoimmune disease concomitance among inflammatory bowel disease patients in the United States, 2001-2002","volume":"14","author":"Cohen","year":"2008","journal-title":"Inflamm Bowel Dis"},{"key":"R19-62-20210226","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.semarthrit.2008.06.004","article-title":"Emergence of Crohn's disease during treatment with the anti-tumor necrosis factor agent etanercept for ankylosing spondylitis: possible mechanisms of action","volume":"39","author":"Haraoui","year":"2009","journal-title":"Semin Arthritis Rheum"},{"key":"R20-62-20210226","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1136\/bmj.2.5054.1157","article-title":"Ankylosing spondylitis and chronic inflammatory lesions of the intestines","volume":"2","author":"Steinberg","year":"1957","journal-title":"Br Med J"},{"key":"R21-62-20210226","first-page":"299","article-title":"Abnormal bowel permeability in ankylosing spondylitis and rheumatoid arthritis","volume":"12","author":"Smith","year":"1985","journal-title":"J Rheumatol"},{"key":"R22-62-20210226","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/rheumatology\/33.7.644","article-title":"Intestinal permeability in patients with ankylosing spondylitis and their healthy relatives","volume":"33","author":"Martinez-Gonzalez","year":"1994","journal-title":"Br J Rheumatol"},{"key":"R23-62-20210226","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1002\/art.24389","article-title":"Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis","volume":"60","author":"Ciccia","year":"2009","journal-title":"Arthritis Rheum"},{"key":"R24-62-20210226","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0140-6736(02)08215-6","article-title":"Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial","volume":"359","author":"Braun","year":"2002","journal-title":"Lancet"},{"key":"R25-62-20210226","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJMoa012664","article-title":"Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha","volume":"346","author":"Gorman","year":"2002","journal-title":"N Engl J Med"},{"key":"R26-62-20210226","first-page":"2405","article-title":"Clinical characteristics of non-perianal fistulating Crohn's disease in China: a single-center experience of 184 cases","volume":"125","author":"Wang","year":"2012","journal-title":"Chinese Med J"},{"key":"R27-62-20210226","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.crohns.2009.11.005","article-title":"The joint-gut axis in inflammatory bowel diseases","volume":"4","author":"Brakenhoff","year":"2010","journal-title":"J Crohn Colitis"},{"key":"R28-62-20210226","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1111\/j.1572-0241.2001.04705.x","article-title":"Etanercept in the treatment of active refractory Crohn's disease: a single-center pilot trial","volume":"96","author":"D\u2019Haens","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R29-62-20210226","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1053\/gast.2001.28674","article-title":"Etanercept for active Crohn's disease: a randomized, double-blind, placebo-controlled trial","volume":"121","author":"Sandborn","year":"2001","journal-title":"Gastroenterology"},{"key":"R30-62-20210226","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/ard.62.1.74","article-title":"Efficacy of etanercept for treatment of Crohn's related spondyloarthritis but not colitis","volume":"62","author":"Marzo-Ortega","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"R31-62-20210226","first-page":"10.11136bcr","article-title":"Crohns disease unmasked following etanercept treatment for ankylosing spondylitis.","volume":"2013doi","author":"Jethwa","year":"2013","journal-title":"BMJ Case Rep"},{"key":"R32-62-20210226","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1016\/S0016-5085(03)00382-2","article-title":"Infliximab but not etanercept induces apoptosis in lamina propria T-lymphocytes from patients with Crohn's disease","volume":"124","author":"Van den Brande","year":"2003","journal-title":"Gastroenterology"},{"key":"R33-62-20210226","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/MCG.0000000000000421","article-title":"Role of nonsteroidal anti-inflammatory drugs in exacerbations of inflammatory bowel disease","volume":"50","author":"Long","year":"2016","journal-title":"J Clin Gastroenterol"},{"key":"R34-62-20210226","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/MAJ.0b013e3182514059","article-title":"Management of comorbidities in ankylosing spondylitis","volume":"343","author":"Rosenbaum","year":"2012","journal-title":"Am J Med Sci"},{"key":"R35-62-20210226","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/MAJ.0b013e3182959a18","article-title":"Preliminary case-control study to evaluate diagnostic values of C-reactive protein and erythrocyte sedimentation rate in differentiating active Crohn's disease from intestinal lymphoma, intestinal tuberculosis and Behcet's syndrome","volume":"346","author":"Liu","year":"2013","journal-title":"Am J Med Sci"},{"key":"R36-62-20210226","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1136\/annrheumdis-2014-206773","article-title":"CRP and ASDAS are associated with future elevated arterial stiffness, a risk marker of cardiovascular disease, in patients with ankylosing spondylitis: results after 5-year follow-up","volume":"74","author":"Berg","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R37-62-20210226","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1007\/s00296-015-3214-4","article-title":"The clinical usefulness of ESR, CRP, and disease duration in ankylosing spondylitis: the product of these acute-phase reactants and disease duration is associated with patient's poor physical mobility","volume":"35","author":"Chen","year":"2015","journal-title":"Rheumatol Int"},{"key":"R38-62-20210226","doi-asserted-by":"crossref","first-page":"e804","DOI":"10.1097\/MD.0000000000000804","article-title":"Prevalence and risk factors of acute lower gastrointestinal bleeding in Crohn disease","volume":"94","author":"Li","year":"2015","journal-title":"Medicine"},{"key":"R39-62-20210226","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/MCG.0000000000000041","article-title":"Exclusive enteral nutritional therapy can relieve inflammatory bowel stricture in Crohn's disease","volume":"48","author":"Hu","year":"2014","journal-title":"J Clin Gastroenterol"},{"key":"R40-62-20210226","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.3748\/wjg.15.2449","article-title":"Clinical features and epidemiology of spondyloarthritides associated with inflammatory bowel disease","volume":"15","author":"Salvarani","year":"2009","journal-title":"World J Gastroenterol"},{"key":"R41-62-20210226","first-page":"1090","article-title":"Rheumatological complications of GI disorders","volume":"91","author":"Fomberstein","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"R42-62-20210226","first-page":"60","article-title":"HLA B27 in regional enteritis with and without ankylosing spondylitis or sacroiliitis","volume":"3","author":"Huaux","year":"1977","journal-title":"J Rheumatol Suppl"},{"key":"R43-62-20210226","doi-asserted-by":"crossref","first-page":"e1001195","DOI":"10.1371\/journal.pgen.1001195","article-title":"Association of variants at 1q32 and STAT3 with ankylosing spondylitis suggests genetic overlap with Crohn's disease","volume":"6","author":"Danoy","year":"2010","journal-title":"PLoS Genet"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000004267","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:29:12Z","timestamp":1620959352000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201607120-00062"}},"subtitle":["A preliminary single-center study"],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":43,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000004267","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]}}}